抗凝固剤に別れを告げるときは?
Julia Czuprynska1, Roopen Arya1
1Department of Haematological Medicine, King's Thrombosis Centre, King's College Hospital NHS Foundation Trust, London, UK.
British journal of haematology
|August 22, 2025
まとめ
終末期がん患者では抗血栓治療の処方箋はまれである. この研究は,この高リスクの患者グループに対して,より高い意識と共有された意思決定の介入の必要性を強調しています.
科学分野:
- 腫瘍学
- 血液学
- 緩和ケア
背景:
- 終末期がん患者の抗血栓治療の決定は複雑です.
- この集団における現在の処方行動と結果はよく理解されていません.
研究 の 目的:
- 生命の終わりに近づいている癌患者の抗血栓治療の処方パターンを調べる.
- このコホートにおける抗血栓療法に関連した臨床結果の調査.
- 患者のケアと意思決定を改善する分野を特定する.
主な方法:
- コホート研究デザインが採用された.
- 人口関連で定期的に収集されたデータは分析に使用された.
- 処方行動と臨床結果が検討された.
主要な成果:
- この患者群では,抗血栓治療の処方が稀であることが判明しました.
- この研究では,特定の処方行動と関連する臨床結果が特定されました.
- 処方停止に関するケアにおけるギャップが観察されました.
結論:
- 終末期がん治療における抗血栓治療の管理についてより高い認識が必要である.
- 共同意思決定を支援する介入が必要である.
- 医療のこの見過ごされた側面は 患者の治療結果を改善するために 集中的な注意が必要です
関連する概念動画
Venous Thrombosis III: Interprofessional Care
22
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
22
Anticoagulant Drugs: Low-Molecular-Weight Heparins
893
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
893
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
1.3K
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
1.3K
Venous Thrombosis IV: Nursing Management
23
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
23
Pulmonary Embolism III: Nursing Management
38
A pulmonary embolism occurs when a thrombus, amniotic fluid, tumor tissue, fat, or air embolus blocks one or more pulmonary arteries. Effective nursing management and patient education are crucial for improving outcomes and preventing recurrence.Nursing management starts with obtaining a comprehensive patient history, particularly noting any history of deep vein thrombosis (DVT). Assess for clinical manifestations, including dyspnea, chest pain, crackles, heart murmurs, and signs of right-sided...
38
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
44
Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
44


